High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes

被引:61
|
作者
Di Pino, A. [1 ]
Currenti, W. [1 ]
Urbano, F. [1 ]
Scicali, R. [1 ]
Piro, S. [1 ]
Purrello, F. [1 ]
Rabuazzo, A. M. [1 ]
机构
[1] Univ Catania, Dept Clin & Expt Med, Catania, Italy
关键词
Type; 2; diabetes; Dietary advanced glycation end-products; Cardiovascular disease; Soluble receptor for advanced glycation endproducts; Inflammation; CORONARY-HEART-DISEASE; SOLUBLE RECEPTOR; OXIDATIVE STRESS; GLYCOXIDATION; GLYCOTOXINS; RISK; MORTALITY;
D O I
10.1016/j.numecd.2017.06.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Modern diets are high in advanced glycation end-products (dAGEs), derived from processing methods, exerting a pivotal role in promoting atherosclerotic risk. In this cross-sectional study we investigate the relationship between dAGE intake, arterial stiffness, inflammatory profile and macronutrient composition, in subjects with type 2 diabetes without overt cardiovascular disease. Methods and results: Arterial stiffness, carboxy-methyl-lysine, endogenous secretory receptor for AGEs (esRAGE), high sensitivity C reactive protein (hs-CRP), S100A12 and macronutrient intake were evaluated in 85 subjects with type 2 diabetes. The subjects were stratified into two groups according to dAGE consumption: high and low dAGE intake (>= or < 15.000 kU/day, respectively). Subjects with high dAGE intake (n = 45) showed a higher augmentation, augmentation index and pulse wave velocity (PWV) compared with those subjects with low dAGE intake (18 +/- 5.4 vs 12.2 +/- 6.3 mmHg, P < 0.05; 38.3 +/- 5.4 vs 29.3 +/- 10%; 9.2 +/- 1.4 m/sec vs 7.9 +/- 1.7, P < 0.05, respectively). hs-CRP were higher in subjects with high dAGE intake [0.42 (0.18 -.54) vs 0.21 (0.14-.52) mg/dL, P < 0.05] whereas esRAGE plasma levels were lower [0.16 (0.23-.81) vs 0.2 (0.14-.54) ng/dL, P < 0.05]. Simple regression analysis showed a correlation between dAGEs and fat intake. Multivariate analysis showed an independent association between augmentation, systolic blood pressure (BP) and dAGE consumption; BMI and esRAGE were the major determinants of PWV. Conclusions: Our data suggests that a chronic high dAGE diet could lead to a vascular dysfunction and inflammatory activation, contributing to the development of vascular complications in subjects with type 2 diabetes. Testing this hypothesis may represent a direction of future research. (C) 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:978 / 984
页数:7
相关论文
共 50 条
  • [31] Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development
    Du, Chenping
    Whiddett, Rani O.
    Buckle, Irina
    Chen, Chen
    Forbes, Josephine M.
    Fotheringham, Amelia K.
    CELLS, 2022, 11 (21)
  • [32] Cilostazol attenuates the severity of peripheral arterial disease in type 2 diabetes: the plasma soluble receptor for advanced glycation end-products
    Liu, Jhih-Syuan
    Hung, Yi-Jen
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S144 - S144
  • [33] Serum level of soluble receptor for advanced glycation end products is associated with circulating advanced glycation end products in type 2 diabetes
    Tan, K. C. B.
    Chow, W. S.
    Shiu, S. W. M.
    Bucala, R.
    Betteridge, D. J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 294 - 294
  • [34] High Serum Advanced Glycation End-Products Predict Coronary Artery Disease Irrespective of Arterial Stiffness in Diabetic Patients
    Won, Ki-Bum
    Chang, Hyuk-Jae
    Park, Sung-Ha
    Hong, Sung-Yu
    Jang, Yangsoo
    Chung, Namsik
    KOREAN CIRCULATION JOURNAL, 2012, 42 (05) : 335 - 340
  • [35] Lung cancer and diabetes: A role for advanced glycation end-products?
    Rigalleau, Vincent
    Foussard, Ninon
    Bertrand, Alexia
    Monlun, Marie
    Blanco, Laurence
    Mohammedi, Kamel
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (01)
  • [36] Dietetics advanced glycation end-products and chronic complications of diabetes
    Porto Barbosa, Junia Helena
    de Oliveira, Suzana Lima
    Tojal e Seara, Luci
    REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION, 2009, 22 (01): : 113 - 124
  • [37] POLYMORPHISMS IN THE ADVANCED GLYCATION END-PRODUCTS RECEPTOR GENE AND ARTERIAL STIFFNESS IN A TREATMENT NIAVE HYPERTENSIVE POPULATION
    Mahmud, A.
    Yasmin, Y.
    Zhou, S.
    Feely, J.
    Silke, B.
    JOURNAL OF HYPERTENSION, 2015, 33 : E309 - E309
  • [38] Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus
    Kalousová, M
    Skrha, J
    Zima, T
    PHYSIOLOGICAL RESEARCH, 2002, 51 (06) : 597 - 604
  • [39] Correlation between serum advanced glycation end-products and vascular complications in patient with type 2 diabetes
    Kato, Sayuri
    Matsumura, Takeshi
    Sugawa, Hikari
    Nagai, Ryoji
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [40] Sclerostin Regulation, Microarchitecture, and Advanced Glycation End-Products in the Bone of Elderly Women With Type 2 Diabetes
    Piccoli, Alessandra
    Cannata, Francesca
    Strollo, Rocky
    Pedone, Claudio
    Leanza, Giulia
    Russo, Fabrizio
    Greto, Valentina
    Isgro, Camilla
    Quattrocchi, Carlo Cosimo
    Massaroni, Carlo
    Silvestri, Sergio
    Vadala, Gianluca
    Bisogno, Tiziana
    Denaro, Vincenzo
    Pozzilli, Paolo
    Tang, Simon Y.
    Silva, Matt J.
    Conte, Caterina
    Papalia, Rocco
    Maccarrone, Mauro
    Napoli, Nicola
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 (12) : 2415 - 2422